Alpha Cognition (NASDAQ:ACOG - Get Free Report)'s stock had its "buy" rating reiterated by HC Wainwright in a report issued on Monday,Benzinga reports. They presently have a $20.00 target price on the stock. HC Wainwright's price objective indicates a potential upside of 293.70% from the stock's previous close.
Separately, Raymond James raised shares of Alpha Cognition to a "moderate buy" rating in a research note on Tuesday, March 25th.
Get Our Latest Stock Analysis on ACOG
Alpha Cognition Price Performance
Shares of NASDAQ ACOG traded up $0.23 on Monday, hitting $5.08. The company had a trading volume of 28,595 shares, compared to its average volume of 77,693. The firm has a market cap of $81.38 million, a price-to-earnings ratio of -1.98 and a beta of 2.50. Alpha Cognition has a 12-month low of $4.66 and a 12-month high of $7.00. The company has a 50 day moving average price of $5.81.
Alpha Cognition (NASDAQ:ACOG - Get Free Report) last posted its quarterly earnings results on Monday, March 31st. The company reported ($0.51) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.48) by ($0.03).
Institutional Trading of Alpha Cognition
Institutional investors and hedge funds have recently modified their holdings of the business. Rosalind Advisors Inc. purchased a new stake in shares of Alpha Cognition during the 4th quarter valued at $1,489,000. Sphera Funds Management LTD. purchased a new stake in Alpha Cognition in the fourth quarter worth approximately $3,652,000. Tudor Investment Corp ET AL bought a new position in Alpha Cognition in the fourth quarter worth approximately $412,000. Alyeska Investment Group L.P. bought a new stake in shares of Alpha Cognition during the 4th quarter valued at $2,356,000. Finally, Bleichroeder LP purchased a new stake in Alpha Cognition in the 4th quarter worth $1,024,000.
Alpha Cognition Company Profile
(
Get Free Report)
Alpha Cognition, Inc is a clinical stage biopharmaceutical company that develops treatments for underserved neurodegenerative diseases such as Alzheimer's Dementia and Amyotrophic Lateral Sclerosis. The company was founded in 2000 and is headquartered in Vancouver, Canada.
See Also
Before you consider Alpha Cognition, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Alpha Cognition wasn't on the list.
While Alpha Cognition currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
